Director, CMC Drug Substance
Olema Oncology
About this role
The Director, CMC Drug Substance at Olema Oncology leads late-stage development, technology transfer to CDMOs, and commercial readiness for small molecule drug substances. This role ensures successful scale-up, validation, and regulatory approval of drug substance processes.
Skills
Qualifications
About Olema Oncology
olema.comOlema Oncology is a cancer medicines company focused on innovating therapies for breast cancer and other endocrine-driven tumors. The company is rapidly advancing a pipeline of drug candidates designed to target the biology of endocrine-driven disease. Olema’s work centers on translating cutting‑edge science into treatments that meaningfully impact patients, progressing programs toward clinical evaluation.
Recent company news
SahmOlema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1 week ago
Yahoo FinanceOlema Oncology Announces Departure of Chief Operating and Financial Officer
1 month ago
Stock TitanBreast cancer-focused Olema sees financial officer depart, CEO steps in
1 month ago
GlobeNewswireOlema Oncology to Present at the TD Cowen 46th Annual Health Care Conference
3 weeks ago
Yahoo FinanceOlema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock
Nov 19, 2025
About Olema Oncology
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Olema Oncology.
Salary
$159k – $232k
per year
More jobs at Olema Oncology
Similar Jobs
Drug Substance Scientist / Manager (CMC – API)
Eurofins
Drug Substance Scientist / Manager (CMC – API)
Eurofins
CMC & Manufacturing, Science and Technology Drug Substance Lead
Sobi
Associate Director, Drug Substance
Sanofi
Senior Director, Analytical Development, CMC Small Molecule
Centessa Pharmaceuticals, LLC
Associate Director, Chemical Development
Nuvalent, Inc.